22 May 2013
Keywords: Gilead, Arresto, IPF, Lung cancer, Pulmonary fibrosis, M&A
Article | 21 December 2010
USA-based Gilead Sciences (Nasdaq: GILD) has signed a definitive agreement to acquire privately-held US biotech firm Arresto Biosciences. Under the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 December 2010
21 May 2013
© 2013 thepharmaletter.com